Bortezomib for Reduction of Proteinuria in IgA Nephropathy

INTRODUCTION: IgA nephropathy is the most common glomerulonephritis in the world. We conducted a pilot trial (NCT01103778) to test the effect of bortezomib in patients with IgA nephropathy and significant proteinuria. METHODS: We treated 8 consecutive subjects from July 2011 until March 2016 with 4...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Kidney Int Rep
Asıl Yazarlar: Hartono, Choli, Chung, Miriam, Perlman, Alan S., Chevalier, James M., Serur, David, Seshan, Surya V., Muthukumar, Thangamani
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2018
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6035125/
https://ncbi.nlm.nih.gov/pubmed/29988921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2018.03.001
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller